Russia said it is ready to conduct clinical trials of its Sputnik V COVID-19 vaccine combined with a vaccine developed by AstraZeneca in Ukraine, the head of Russian Direct Investment Fund (RDIF), Reuters reported.
Ukraine reiterated that it will use only those vaccines against COVID-19 that have successfully passed the third phase of clinical trials. “Today, there are vaccines against COVID-19 that are approved for use under special procedures (emergency use authorization). Interim clinical trial reports were used for such registration. Based on this, Ukraine has decided on the possibility of registering vaccines that are registered in countries with strict regulatory policies. I emphasize: only under these conditions will we allow vaccines to be used,” Deputy Minister of Health Viktor Lyashko wrote in a Facebook post.
Previously, RDIF announced that it was to start production of its unconfirmed vaccine on the territory of Ukraine.